An Open-Trial of Web-Prolonged Exposure (Web-PE) Among Active-Duty Military

Sponsor
University of Pennsylvania (Other)
Overall Status
Completed
CT.gov ID
NCT03337750
Collaborator
University of Texas (Other), VA Palo Alto Health Care System (U.S. Fed)
34
2
1
24
17
0.7

Study Details

Study Description

Brief Summary

It is urgent to make evidence-based treatments (EBTs) for military personnel readily accessible in order to meet the growing demand for effective and efficient treatment for posttraumatic stress disorder (PTSD) in a timely manner. Effective EBTs for PTSD are available, but barriers to accessing care can deter military personnel from receiving treatment. Web-treatments represent an innovative way to overcome these barriers. The efficacy of previously developed web-treatments for PTSD appear promising, however, they are not based on treatment protocols with strong empirical support for their efficacy. No study to date has examined web-treatment of PTSD using a well-established treatment program.

The purpose of this open trial is to examine the efficacy of 10 sessions of a web-version of Prolonged Exposure (PE), "Web-PE," delivered over 8-weeks in 40 active-duty military personnel and veterans with PTSD who deployed post 9-11. Up to 60 individuals will be consented to obtain data from 40 for analysis. Participants will be assessed at pre-treatment and 1- and 3-months after treatment completion.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Web-PE Therapy
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
34 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
An Open-Trial of Web-Prolonged Exposure (Web-PE) Among Active-Duty Military
Actual Study Start Date :
Feb 12, 2018
Actual Primary Completion Date :
Mar 27, 2019
Actual Study Completion Date :
Feb 14, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Web-PE

Ten 60-minute psychotherapy sessions over 8 weeks, focused on gradually confronting distressing trauma-related memories and reminders. Web-PE is an internet-based version of prolonged exposure (PE) for posttraumatic stress disorder (PTSD).

Behavioral: Web-PE Therapy
Ten 60-minute psychotherapy sessions over 8 weeks, focused on gradually confronting distressing trauma-related memories and reminders. Web-PE is an internet-based version of prolonged exposure (PE) for posttraumatic stress disorder (PTSD).
Other Names:
  • Internet-based prolonged exposure
  • Outcome Measures

    Primary Outcome Measures

    1. PTSD CheckList-5 (PCL-5) [Change from baseline to 1-month follow-up (post-treatment)]

      A 20-item self-report measure of PTSD symptoms as defined by the DSM-5. Higher scores indicate greater PTSD symptom severity.

    Secondary Outcome Measures

    1. Patient Health Questionnaire-9 (PHQ-9) [Change from baseline to 1-month follow-up (post-treatment)]

      A 9-item measure of the severity of depressive symptoms. Higher scores indicated greater depressive symptom severity.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 65 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Active-duty military personnel and veterans who have deployed post 9/11

    • Seeking treatment for PTSD

    • Significant PTSD symptoms as determined by a PCL-5 score greater than or equal to 31

    • Has experienced a Criterion A event that is a specific combat-related event or high magnitude operational experience that occurred during a period of recent military deployment

    • Able to speak and read English and access to an internet-connected computer

    • Indication that the participant plans to be able to participant in the study for the next three months following the first assessment

    Exclusion Criteria:
    • Diagnosis of bipolar disorder or psychotic disorder, as determined by participant self-report)

    • Current substance dependence, as determined by participant self-report)

    • Diagnosis of a moderate or severe traumatic brain injury, as determined by participant self-report)

    • Current suicidal ideation severe enough to warrant immediate attention, as determined by participant self-report)

    • Currently engaged in evidence-based treatment for PTSD (e.g. Prolonged Exposure Therapy or Cognitive Processing Therapy), as determined by participant self-report.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Center for the Treatment and Study of Anxiety, University of Pennsylvania Philadelphia Pennsylvania United States 19104
    2 University of Texas Health Science Center at San Antonio San Antonio Texas United States 78229

    Sponsors and Collaborators

    • University of Pennsylvania
    • University of Texas
    • VA Palo Alto Health Care System

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    None provided.
    Responsible Party:
    Carmen McLean, Adjunct Assistant Professor, University of Pennsylvania
    ClinicalTrials.gov Identifier:
    NCT03337750
    Other Study ID Numbers:
    • HSC20170600H
    First Posted:
    Nov 9, 2017
    Last Update Posted:
    Feb 19, 2020
    Last Verified:
    Feb 1, 2020
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Carmen McLean, Adjunct Assistant Professor, University of Pennsylvania
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Feb 19, 2020